Kingdon Capital Management’s Genocea Biosciences, Inc. GNCA Stock Holding History

Kingdon Capital Management’s Portfolio GNCA Stock Details GNCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,972,056	Closed	-$2.46M	–	102
2022 Q1	$2.46M	Hold	1,972,056	–	–	0.26%	66
2021 Q4	$2.29M	Hold	1,972,056	–	–	0.26%	64
2021 Q3	$3.79M	Hold	1,972,056	–	–	0.46%	42
2021 Q2	$4.62M	Hold	1,972,056	–	–	0.53%	48
2021 Q1	$5.34M	Hold	1,972,056	–	–	0.55%	45
2020 Q4	$4.77M	Buy	1,972,056 +1,260,504	+177%	+$2.87M	0.52%	43
2020 Q3	$1.63M	Hold	711,552	–	–	0.18%	57
2020 Q2	$1.64M	Hold	711,552	–	–	0.15%	51
2020 Q1	$1.22M	Sell	711,552 -21,498	-3%	-$43.4K	0.22%	47
2019 Q4	$1.52M	Buy	733,050 +46,828	+7%	+$111K	0.23%	46
2019 Q3	$1.99M	Buy	686,222 +20,000	+3%	+$68.3K	0.24%	56
2019 Q2	$2.61M	Buy	+666,222	New	+$3.48M	0.26%	59

Other funds holding GNCA

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

AICPI

ABG Innovation Capital Partners III Central, Hong Kong, Hong Kong $64.5K AUM 1.01% 1-Year Est. Return

Kingdon Capital Management's GNCA Position: Q2 2022 in Review

Kingdon Capital Management sold out of Genocea Biosciences, Inc. (GNCA) in Q2 2022, closing a stake of 1,972,056 shares — an estimated $2.46M sold.

Kingdon Capital Management first reported a position in GNCA in Q2 2019 and held it in 12 quarters. The position peaked at $5.34M in Q1 2021. 5 funds tracked by Wall St. Rank hold GNCA as of Q2 2022.

Kingdon Capital Management reported no remaining Genocea Biosciences, Inc. position as of Q2 2022 after selling out during the quarter.
Kingdon Capital Management sold 1,972,056 Genocea Biosciences, Inc. shares in Q2 2022, an estimated $2.46M.
Kingdon Capital Management first reported a position in Genocea Biosciences, Inc. in Q2 2019 and held it in 12 quarters.
Kingdon Capital Management's Genocea Biosciences, Inc. position peaked at $5.34M in Q1 2021.
5 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q2 2022.

Based on Kingdon Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.